Characterization of biologic properties of wound fluid collected during early stages of wound healing.
The clinical effects of occlusive dressings on wound healing are well documented. However, the underlying biologic mechanisms associated with moist healing are not well understood. Experimental studies and clinical experience have shown enhanced eschar and clot removal, re-epithelialization, and collagen synthesis under occlusion, suggesting the possibility of elevated activities of proteinases and other effectors, e.g., growth factors, in the moist wound environment. To gain an insight into the biology of early wounds under occlusion, we have carried out biologic and biochemical analyses on fluids from occluded full- and partial-thickness wounds. Metalloproteinase activities were detected in the wound fluid samples. When applied to cultured dermal fibroblasts, mitogenic activity was observed with fluids from full-thickness wounds. Wound fluid-stimulated accumulation of urokinase-type plasminogen activator by fibroblasts was also observed in a time-dependent manner. Stimulation of metalloproteinase accumulation by fibroblasts was also observed. We have further demonstrated the presence of platelet-derived growth factor-like and basic fibroblast growth factor-like factors in wound fluid by antibody neutralization of their biologic activities. Proteinase presence and proteinase stimulatory activity of wound fluid retained in the occluded wound may contribute to an enhanced proteolytic environment in these wounds in comparison to non-occluded "dry" wounds. The presence of growth factors and the potential abilities of proteinases to activate latent growth factors and generate chemotactic peptides through connective tissue breakdown may also contribute to the enhanced healing of occluded wounds.
Chen
W Y
WY
ConvaTec Wound Healing Research Institute, Deeside, Clwyd, U.K.
Rogers
A A
AA
Lydon
M J
MJ
D000818:Animals; D002846:Chromatography, Affinity; D010450:Endopeptidases / Q000032:analysis; D005122:Exudates and Transudates / Q000737:chemistry / Q000502:physiology*; D016222:Fibroblast Growth Factor 2 / Q000502:physiology; D005347:Fibroblasts / Q000201:enzymology; D006801:Humans; D013552:Swine; D014568:Urokinase-Type Plasminogen Activator / Q000096:biosynthesis; D014945:Wound Healing / Q000502:physiology*
D016222:Fibroblast Growth Factor 2; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator